1. Hongyi Zhao,# Shengnan Li,# Shihao Cheng, Ziyun Lin, Dongfeng Zhang* and Haihong Huang*, A mild and metal-free synthesis of chiral 2,3-dihydro-3-hydroxymethyl-1,4-benzoxazines, Tetrahedron, 2021, 10.1016/j.tet.2021.132304 (IF=2.233)
2. Xiao Wang,# Wenting Zhao,# Bin Wang, Wei Ding, Hao Guo, Hongyi Zhao, Jianzhou Meng, Sihan Liu, Yu Lu, Yishuang Liu*, Dongfeng Zhang*. Identification of inhibitors targeting polyketide synthase 13 of Mycobacterium tuberculosis as antituberculosis drug leads. Bioorganic Chemistry, 2021, 10.1016/j.bioorg.2021.105110 (IF=4.831)
3. Dongfeng Zhang,# Peng Li,# Yongxin Gao, Yaoyao Song, Yaqin Zhu, Hong Su, Beibei Yang, Li Li, Gang Li, Ningbo Gong, Yang Lu, Huanjie Shao,* Chunrong Yu,* and Haihong Huang*. Discovery of a Candidate Containing an (S) 3,3-Difluoro-1-(4-methylpiperazin-1-yl)-2,3-dihydro 1H inden Scaffold as a Highly Potent Pan-Inhibitor of the BCR-ABL Kinase Including the T315I Resistant Mutant for the Treatment of Chronic Myeloid Leukemia. Journal of Medicinal Chemistry, 2021, 64(11), 7434−7452 (IF=6.205)
4. Yongqi Wu, Bin Wang, Haijia Lu, Hongyi Zhao, Beibei Yang, Li Li, Yu Lu, Dongfeng Zhang*, Ning Sun*, Haihong Huang*. Identification of novel tricyclic benzo[1,3]oxazinyloxazolidinones as potent antibacterial agents with excellent pharmacokinetic profiles against drug-resistant pathogens. Journal of Medicinal Chemistry, 2021, 64(6), 3234−3248 (IF=6.205)
5. Hongyi Zhao, Bin Wang, Lei Fu, Gang Li, Haijia Lu, Yuke Liu, Li Sheng, Yan Li, Baoxi Zhang, Yang Lu, Chen Ma, Haihong Huang*, Dongfeng Zhang*, and Yu Lu*. Discovery of a conformationally constrained oxazolidinone with improved safety and efficacy profiles for the treatment of multidrug-resistant tuberculosis. Journal of Medicinal Chemistry, 2020, 63(17), 9316-9339 (IF=6.205)
6. Hongyi Zhao, Wenting Zhao, Shihao Cheng, Haijia Lu, Dongfeng Zhang*, and Haihong Huang*, Efficient and stereoselective one-pot synthesis of benzo[b]oxazolo[3,4-d][1,4]oxazin-1-ones, RSC Advances, 2020, 10, 24037-24044 (IF=3.049)
7. Wenting Zhao, Bin Wang, Yuke Liu, Lei Fu, Li Sheng, Hongyi Zhao, Yu Lu, Dongfeng Zhang*, Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis. European Journal of Medicinal Chemistry, 2020, 189, 112075 (IF=5.572)
8. Yong-Qi Wu, Hai-Jia Lu, Wen-Ting Zhao, Hong-Yi Zhao, Zi-Yun Lin, Dong-Feng Zhang*, and Hai-Hong Huang*, A convenient and efficient H2SO4-promoted regioselective monobromination of phenol derivatives using N-bromosuccinimide, Synthetic Communications, 2020, 50(6), 813-822 (IF=1.796)
9. Keli Cui, Meng Gao, Hongyi Zhao, Dongfeng Zhang*, Hong Yan* and Haihong Huang*. An Efficient Synthesis of Aryl-Substituted Pyrroles by the Suzuki–Miyaura Coupling Reaction of SEM-Protected Pyrroles. Molecules, 2019, 24(8), 1594 (IF=3.098)
10. Dongfeng Zhang, Yun Lin, Xi Chen, Wenting Zhao, Dongni Chen, Meng Gao, Qinglin Wang, Bin Wang, Haihong Huang*, Yongjun Lu*, Yu Lu*. Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold. Bioorganic Chemistry, 2019, 85, 229-239 (IF=4.831)
11. Meng Gao, Wenting Zhao, Hongyi Zhao, Ziyun Lin, Dongfeng Zhang* and Haihong Huang*. An efficient and facile access to highly functionalized pyrrole derivatives. Beilstein Journal of Organic Chemistry, 2018, 14, 884-890 (IF=2.597)
12. Hongyi Zhao, Yu Lu, Li Sheng, Zishuo Yuan, Bin Wang, Weiping Wang, Yan Li, Chen Ma, Xiaoliang Wang, Dongfeng Zhang*, and Haihong Huang*. Discovery of fluorine-containing benzoxazinyl-oxazolidinones for the treatment of multidrug resistant tuberculosis. ACS Medicinal Chemistry Letters, 2017, 8 (5), 533-537 (IF=3.407)
13. Dongfeng Zhang, Peng Li, Ziyun Lin, Haihong Huang*. An improved synthesis of (1S,4S)-2-oxa-5-azabicyclo[2.2.1]heptane. Chinese Chemical Letters, 2014, 45(3), 479-481 (IF=1.822)
14. Dongfeng Zhang, Peng Li, Ziyun Lin, Haihong Huang*. An efficient and convenient protocol for synthesis of 1,1-difluoro-6-nitro-2,3-dihydro-1H-indene derivatives. Synthesis, 2014, 46(5), 613-620 (IF=2.664)
15. Dongfeng Zhang, Yang Liu, Chunlin Zhang, Hao Zhang, Bin Wang, Jian Xu, Lei Fu, Dali Yin, Christopher B. Cooper, Zhenkun Ma*, Yu Lu*, and Haihong Huang*. Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agents. Molecules, 2014, 19(4), 4380-4394 (IF=2.581)
16. Dongfeng Zhang#, Yu Lu#, Kai Liu, Binna Liu, Jingbin Wang, Gang Zhang, Hao Zhang, Yang Liu, Bin Wang, Meiqin Zheng, Lei Fu, Yanyan Hou, Ningbo Gong, Yang Lv, Chun Li, Christopher B. Cooper, Anna M. Upton, Dali Yin, Zhenkun Ma*, and Haihong Huang*. Identification of less lipophilic riminophenazine derivatives for the treatment of drug-resistant tuberculosis. Journal of Medicinal Chemistry, 2012, 55(19), 8409-8417 (IF=5.765)
17. 鲁海嘉,张东峰*,黄海洪,抗革兰氏阴性菌药物的研究进展,药学学报,2019, 54(9), 1554-1563
18. 丁威,赵文婷,张东峰*,结核分枝杆菌聚酮合成酶13抑制剂的研究进展,药学学报, 2020, 55(8), 1768-1773